Telix Pharmaceuticals (Telix Pharmaceuticals) Other Gross PPE : $8.7 Mil (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Telix Pharmaceuticals Other Gross PPE?

Telix Pharmaceuticals's Other Gross PPE for the quarter that ended in Dec. 2023 was $8.7 Mil.

Telix Pharmaceuticals's quarterly Other Gross PPE declined from Dec. 2022 ($7.2 Mil) to Jun. 2023 ($0.0 Mil) but then increased from Jun. 2023 ($0.0 Mil) to Dec. 2023 ($8.7 Mil).

Telix Pharmaceuticals's annual Other Gross PPE increased from Dec. 2021 ($3.0 Mil) to Dec. 2022 ($7.2 Mil) and increased from Dec. 2022 ($7.2 Mil) to Dec. 2023 ($8.7 Mil).

Telix Pharmaceuticals Other Gross PPE Historical Data

The historical data trend for Telix Pharmaceuticals's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Telix Pharmaceuticals Other Gross PPE Chart

Telix Pharmaceuticals Annual Data

Trend

Sep99

Sep00

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Gross PPE

Get a 7-Day Free Trial

1.38

2.10

3.02

7.21

8.74

Telix Pharmaceuticals Semi-Annual Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Other Gross PPE	Get a 7-Day Free Trial								3.02	-	7.21	-	8.74

Telix Pharmaceuticals Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.

Telix Pharmaceuticals (Telix Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Telix Pharmaceuticals Ltd (OTCPK:TLPPF) » Definitions » Other Gross PPE

Comparable Companies

Traded in Other Exchanges

TLX:Australia

Address

55 Flemington Road, Suite 401, North Melbourne, Melbourne, VIC, AUS, 3051

Website

https://www.telixpharma.com

Telix Pharmaceuticals Ltd is a clinical-stage biotechnology company engaged in developing and commercializing molecularly-targeted radiation therapy to address the unmet needs in the management of prostate, renal (kidney) and glioblastoma (brain) cancer. Geographically, it operates in Australia, the United States, Belgium, and Japan.